|
ZNF496 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.25289999988831E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.48719925263663E-11 |
| Normal-vs-Stage2 |
6.938700E-03 |
| Normal-vs-Stage3 |
1.560410E-02 |
| Normal-vs-Stage4 |
5.768000E-01 |
| Stage1-vs-Stage2 |
2.199000E-01 |
| Stage1-vs-Stage3 |
1.638700E-03 |
| Stage1-vs-Stage4 |
5.83940000020711E-07 |
| Stage2-vs-Stage3 |
2.950000E-01 |
| Stage2-vs-Stage4 |
3.119900E-02 |
| Stage3-vs-Stage4 |
1.273770E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.05030000030482E-07 |
| Normal-vs-AfricanAmerican |
5.221600E-03 |
| Normal-vs-Asian |
2.819800E-02 |
| Caucasian-vs-AfricanAmerican |
7.083400E-01 |
| Caucasian-vs-Asian |
1.132240E-01 |
| AfricanAmerican-vs-Asian |
2.147800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.44850000003161E-06 |
| Normal-vs-Female |
3.76509999844288E-08 |
| Male-vs-Female |
1.022420E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.058770E-01 |
| Normal-vs-Age(41-60Yrs) |
5.2724000054738E-08 |
| Normal-vs-Age(61-80Yrs) |
1.63807999999932E-05 |
| Normal-vs-Age(81-100Yrs) |
4.185200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.529800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.413000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.854600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.668600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.636350E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.308000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.89619999999557E-05 |
| Normal-vs-Grade 2 |
1.54189994105991E-10 |
| Normal-vs-Grade 3 |
1.437010E-04 |
| Normal-vs-Grade 4 |
9.059600E-01 |
| Grade 1-vs-Grade 2 |
1.463920E-02 |
| Grade 1-vs-Grade 3 |
1.255930E-03 |
| Grade 1-vs-Grade 4 |
1.48929999999048E-07 |
| Grade 2-vs-Grade 3 |
1.954370E-02 |
| Grade 2-vs-Grade 4 |
2.40210000002072E-07 |
| Grade 3-vs-Grade 4 |
1.838990E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.34114941374719E-13 |
| Normal-vs-ccB subtype |
3.261800E-02 |
| ccA subtype-vs-ccB subtype |
1.59349999995229E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.51851999999897E-05 |
| Normal-vs-N1 |
9.893800E-01 |
| N0-vs-N1 |
1.244040E-01 |
|
|
